129 related articles for article (PubMed ID: 7389854)
21. Vaccination of rats against Fasciola hepatica.
Howell MJ
J Parasitol; 1979 Oct; 65(5):817-9. PubMed ID: 512775
[No Abstract] [Full Text] [Related]
22. The identification of soluble adult antigen on the tegumental surface of juvenile Fasciola hepatica.
Bennett CE
Parasitology; 1978 Dec; 77(3):325-32. PubMed ID: 372892
[TBL] [Abstract][Full Text] [Related]
23. Production and characterization of monoclonal antibodies against excretory-secretory products of Fasciola hepatica.
Solano M; Ridley RK; Minocha HC
Vet Parasitol; 1991 Nov; 40(3-4):227-39. PubMed ID: 1788930
[TBL] [Abstract][Full Text] [Related]
24. Fasciola hepatica L. and fascioliasis: physiological, biochemical, pathogenic, immunologic, and diagnostic aspects.
Locatelli A; Simonic T
Folia Vet Lat; 1974 Jan; 4(1):43-70. PubMed ID: 4603539
[No Abstract] [Full Text] [Related]
25. Adjuvant-enhanced antibody and cellular responses to inclusion bodies expressing FhSAP2 correlates with protection of mice to Fasciola hepatica.
Rivera F; Espino AM
Exp Parasitol; 2016 Jan; 160():31-8. PubMed ID: 26632503
[TBL] [Abstract][Full Text] [Related]
26. An immunofluorescence reaction for Fasciola hepatica using the defined antigen substrate spheres (DASS) system.
Deelder AM; Ploem JS
Exp Parasitol; 1975 Apr; 37(2):173-8. PubMed ID: 1091494
[No Abstract] [Full Text] [Related]
27. Serum antibody isotype responses of Fasciola-infected sheep and cattle to excretory and secretory products of Fasciola species.
Phiri IK; Phiri AM; Harrison LJ
Vet Parasitol; 2006 Nov; 141(3-4):234-42. PubMed ID: 16797844
[TBL] [Abstract][Full Text] [Related]
28. Fasciola hepatica: an electron microscope autoradiographic study of protein synthesis and secretion by gut cells in tissue slices.
Hanna RE
Exp Parasitol; 1975 Oct; 38(2):167-80. PubMed ID: 1175725
[No Abstract] [Full Text] [Related]
29. Peritoneal lavage cells of Indonesian thin-tail sheep mediate antibody-dependent superoxide radical cytotoxicity in vitro against newly excysted juvenile Fasciola gigantica but not juvenile Fasciola hepatica.
Piedrafita D; Estuningsih E; Pleasance J; Prowse R; Raadsma HW; Meeusen EN; Spithill TW
Infect Immun; 2007 Apr; 75(4):1954-63. PubMed ID: 17210661
[TBL] [Abstract][Full Text] [Related]
30. Fasciola hepatica: an immunofluorescent study of antigenic changes in the tegument during development in the rat and the sheep.
Hanna RE
Exp Parasitol; 1980 Oct; 50(2):155-70. PubMed ID: 6997065
[No Abstract] [Full Text] [Related]
31. Fasciola hepatica: migration of newly excysted juveniles in resistant rats.
Burden DJ; Bland AP; Hammet NC; Hughes DL
Exp Parasitol; 1983 Oct; 56(2):277-88. PubMed ID: 6617806
[TBL] [Abstract][Full Text] [Related]
32. Precipitating antibodies against excretory/secretory antigens of Fasciola hepatica in sheep serum.
Sandeman RM; Howell MJ
Vet Parasitol; 1981 Oct; 9(1):35-46. PubMed ID: 6178206
[TBL] [Abstract][Full Text] [Related]
33. Solubilization of antigens of Fasciola hepatica which react with antibodies to Schistosoma mansoni.
Hillyer GV; Pelley RP; del Llano de Diaz A
J Parasitol; 1979 Feb; 65(1):55-60. PubMed ID: 448600
[TBL] [Abstract][Full Text] [Related]
34. MM3-ELISA evaluation of coproantigen release and serum antibody production in sheep experimentally infected with Fasciola hepatica and F. gigantica.
Valero MA; Ubeira FM; Khoubbane M; Artigas P; Muiño L; Mezo M; Pérez-Crespo I; Periago MV; Mas-Coma S
Vet Parasitol; 2009 Jan; 159(1):77-81. PubMed ID: 19019548
[TBL] [Abstract][Full Text] [Related]
35. The biological labelling with 75 Se of protein antigens of Fasciola hepatica.
Mulligan W; Cuperlović K; Borojević D; Lalić R
Immunology; 1972 Dec; 23(6):957-60. PubMed ID: 4648855
[TBL] [Abstract][Full Text] [Related]
36. The antigens of Paragonimus westermani, Schistosoma mansoni, and Fasciola hepatica adult worms. Evidence for the presence of cross-reactive antigens and for cross-protection to Schistosoma mansoni infection using antigens of Paragonimus westermani.
Hillyer GV; Serrano AE
Am J Trop Med Hyg; 1983 Mar; 32(2):350-8. PubMed ID: 6404188
[TBL] [Abstract][Full Text] [Related]
37. Antibody recognition of cathepsin L1-derived peptides in Fasciola hepatica-infected and/or vaccinated cattle and identification of protective linear B-cell epitopes.
Garza-Cuartero L; Geurden T; Mahan SM; Hardham JM; Dalton JP; Mulcahy G
Vaccine; 2018 Feb; 36(7):958-968. PubMed ID: 29373193
[TBL] [Abstract][Full Text] [Related]
38. Construction of a novel phage display antibody library against Fasciola hepatica, and generation of a single-chain variable fragment specific for F. hepatica cathepsin L1.
Norbury LJ; Basałaj K; Bąska P; Kalinowska A; Zawistowska-Deniziak A; Yap HY; Wilkowski P; Wesołowska A; Wędrychowicz H
Exp Parasitol; 2019 Mar; 198():87-94. PubMed ID: 30763571
[TBL] [Abstract][Full Text] [Related]
39. Naltrexone; as an efficient adjuvant in induction of Th1 immunity and protection against Fasciola hepatica infection.
Azizi H; Mirzaeei H; Nasiri AA; Bazi A; Mirzapour A; Khatami M; Nahavandi KH; Azimi A; Yaghoobi H
Exp Parasitol; 2018 Jun; 189():66-71. PubMed ID: 29729492
[TBL] [Abstract][Full Text] [Related]
40. Detection of circulating immune complexes by the enzyme-linked immunosorbent assay in sera from cattle infected with Fasciola hepatica.
Langley RJ; Hillyer GV
J Parasitol; 1989 Oct; 75(5):690-5. PubMed ID: 2795372
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
